Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection
PHASE2
The GI-5005 therapeutic vaccine in combination with standard of care or sta...
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ยฑ Dasabuvir, ยฑ Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)
N/A
The interferon-free combination regimen of paritaprevir/r - ombitasvir with...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-03
Trial ID
NCT02615145
Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers
EARLY_PHASE1
This is a non-randomized, open-label study examining the safety and efficac...
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4
PHASE4
The study aims to study the outcome of pharmacokinetics-adjusted dose ribav...